Newcourt Acquisition Corp
Status: Deal Closed
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $250.00M |
|---|---|
| IPO Date | Oct 20, 2021 |
| CEO | Marc Balkin |
| Left Lead | Cantor Fitzgerald |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 15 + 6 + 6 + 1 |
| IPO Sector |
Financial
Financial services and financial technology businesses with exposure to emerging markets |
| IPO Geography | EEMEA |
| Target Company | Psyence Biomed Corp |
| Deal Announced | Jan 9, 2023 |
| Deal Size, $M | $111.00M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings | www.sec.gov |
| Approval Vote | Jan 18, 2024 |
| Amendment Vote | Jan 22, 2024 |
| Closing Date | Jan 25, 2024 |
Formerly NCAC
PBM
PBMWW
| Price | $0.05 |
|---|---|
| Last closing price | $0.05 |
| H/L, today | $0.05 / $0.05 |
| Volume, today | 33,555,628 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Newcourt Acquisition Corp:
- Structure and cap table
- 6 directors & officers
- 49 filings and events
- 1 underwriters
- 2 deal advisors
- 3 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Michael Jordaan | 52 | Chairman of the Board of Directors |
| Marc Balkin | 47 | CEO |
| Jurgen van de Vyver | 34 | CFO |
| Simran Aggarwal | 48 | Director |
| Rohit Bodas | 45 | Director |
| Nicole Farb | 42 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Cantor Fitzgerald | BR | 22,000,000 | units |
| 22,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
5.00 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.